According to filings with the U.S. Securities and Exchange Commission, Althea Technologies is raising up to $1,500,000.00 in new funding. Sources indicate that as part of senior management President, Niko Skievaski played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Althea Technologies
Althea is a private organization formed in partnership with CU Anschutz Department of Psychiatry with the goal of expanding psychedelic research in Colorado. The department recently embarked on the first psychedelic clinical trial in Colorado, exploring the effects of psilocybin on anhedonia in treatment-resistant depression. Additionally, the state of Colorado is embarking on a regulated rollout of a psilocybin assisted therapy program in 2025.

To learn more about Althea Technologies, visit http://www.altheapbc.com/
Althea Technologies Linkedin Page: https://www.linkedin.com/company/althea-pbc/

Contact:
Niko Skievaski, President
480-577-9058
https://www.linkedin.com/in/skievaski/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.